Promore Pharma AB

https://www.promorepharma.com

Promore Pharma is a biopharmaceutical company specialized in the development of therapeutic peptides for the bioactive wound care market. The company’s aim is to develop two first-in-category products for indications where very few efficacious prescription pharmaceuticals are available, thus, addressing high unmet medical needs. Promore Pharma has two projects, PXL01 and LL-37, in late stage clinical phase. PXL01, that will be used for prevention of post-surgical adhesions and scars, is being prepared for clinical phase III-studies on patients undergoing tendon repair surgery in the hand and LL-37 that is prepared for a clinical phase IIb study on patients with venous leg ulcers. The product candidates can also be deployed for other indications, such as preventing dermal scarring and treatment of diabetic foot ulcers. Rosetta Capital Ltd., Midroc New Technology AB and PharmaResearch Products Ltd. are the main shareholders in Promore Pharma. *

	Start	2016-07-01 renamed
	Group	Promore Pharma (Group)
	Predecessor	Pergamum AB
	Industry	pharmaceutical
	Person	Ekblom, Jonas (Pergamum AB 201302 CEO)

	Region	Solna
	Country	Sweden
	Street	2 Fogdevreten Karolinska Institutet Science Park (KISP)
	City	17165 Solna
	Tel	+46-8-1245-4859
		Address record changed: 2020-12-02

Basic data	Employees	n. a.

		* Document for »About Section«: Promore Pharma AB. (5/19/17). "Press Release: Interim Report January - March 2017".

		Record changed: 2024-02-12

Picture EBD Group World of Partnering Opportunities 650x200px

More documents for Promore Pharma (Group)

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)